Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pegylated imidazoquinolines as TLR7 and TLR8 agonists

Pegylated imidazoquinolines as TLR7 and TLR8 agonists

US Patent 10882876 · Granted Jan 5, 2021

Estimated economic value: $20,778,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccine adjuvants based on TLR receptor ligands2025
Toll-like receptor ligands2024
Vaccine adjuvants based on TLR receptor ligands2024
Methods and compositions relating to adjuvants2022
Toll-like receptor ligands2022
Imidazoquinoline derivatives and their use in therapy2022
Imidazoquinoline derivatives and their use in therapy2022
Phospholipidation of imidazoquinolines and oxoadenines2022
Phospholipidation of imidazoquinolines and oxoadenines2022
Compositions and uses2021
Adenine derivatives which are useful in the treatment of allergic diseases or ot2021
Phospholipidation of imidazoquinolines and oxoadenines2020